Related Experiment Video
Updated: Jan 9, 2026

12:15
Generation of Monoclonal Antibodies Against Natural Products
Published on: April 6, 2019
11.5K
An mRNA platform to create isolated, monospecific Th1 responses.
Kathleen S Krauss1,2, Stephen Carro1,3, Michael J Hogan4
1Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, United States.
Journal of Immunology (Baltimore, Md. : 1950)
|December 2, 2025
Summary
Researchers developed a novel mRNA vector for selective immunization, generating a robust, monospecific helper T-cell (CD4 T cell) response. This method effectively elicits CD4 T cells that influence infection outcomes in mouse models.
Area of Science:
- Immunology
- Molecular Biology
- Vaccinology
Background:
- Helper T cells (CD4 T cells) are crucial for adaptive immunity.
- Each CD4 T cell recognizes a specific epitope presented by MHC-II.
- Studying uniform CD4 T-cell populations is challenging due to T-cell receptor diversity.
Purpose of the Study:
- To develop a novel method for generating a monospecific helper T-cell response.
- To create a modular mRNA vector for selective immunization.
- To assess the utility of monospecific CD4 T cells in disease models.
Main Methods:
- A modular mRNA vector was designed to encode a target epitope linked to MHC-II.
- Mice were immunized with the mRNA vector to elicit selective CD4 T-cell responses.
- Ex vivo analysis assessed cytokine release, and in vivo studies used Salmonella enterica and influenza virus models.
Main Results:
- The mRNA vector successfully produced robust, monospecific CD4 T-cell responses across various epitopes and MHC-II alleles.
- The generated CD4 T cells exhibited polyfunctional Th1 cytokine release.
- Monospecific CD4 T cells modulated infection progression in both Salmonella and influenza models.
Conclusions:
- This novel mRNA vector enables the selective generation of monospecific CD4 T-cell populations.
- The produced CD4 T cells are functional and impact infectious disease outcomes.
- This experimental tool offers a valuable approach for studying specific CD4 T-cell responses in immunity and disease.

